Meet two of OPEN Health’s practices – Peloton Advantage and Pharmerit at MAPS 2020
March 3, 2020 |
Turning scientific knowledge and data into evidence
March 3, 2020 – London, UK, Parsippany and Bethesda, USA – Meet two of OPEN Health’s practices—Peloton Advantage and Pharmerit International—at booth #4 at MAPS Global 2020, the World’s Largest Assembly of Medical Affairs Professionals, to be held in Miami, Florida from March 8 – 11, 2020.
Peloton Advantage along with OPEN Health Medical Communications provides expertise in Medical Affairs content and consultancy, publication planning and management, medical education, and internal training. By joining OPEN Health in late 2019, Pharmerit deepens OPEN Health’s strategic and scientific capabilities in health economics and outcomes research (HEOR) and market access and expands Pharmerit’s ability to communicate with the broader scientific community. For more information on the two practices, please visit our website.
OPEN Health practices are supported by creative and digital teams to translate scientific concepts and communications into compelling visuals and deliver innovation with measurable results, all while ensuring data security and compliance. Together, the OPEN Health family is a full-service, trusted, innovative partner for Medical Affairs.
Contact:
OPEN Health: Sandy Royden
sandyroyden@openhealthgroup.com
+44 1628 481112
Peloton Advantage: Carolyn Clark
cclark@pelotonadvantage.com
+1 973 582 5701
Pharmerit International: Candice Subero
+1 240 483 4323
About OPEN Health Communications, LLP:
OPEN Health is a global multidisciplinary health communications and market access group, operating within three core business areas: Medical Communications; Patient and Brand Communications; and HEOR / Access and Evidence. OPEN Health was formed in 2011, and whilst working across a broad therapeutic range has a strong focus on oncology, rare diseases, and specialist medicines.
For further information on OPEN Health, please visit www.openhealthgroup.com.
About Pharmerit International, LP:
Pharmerit International is a global, premier health economics and outcomes research (HEOR) consultancy with 20 years of experience supporting pharmaceutical, biotechnology, and medical device organizations in health economics and outcomes research (HEOR) and market access worldwide. Pharmerit delivers quality research across four multidisciplinary Centers of Excellence: Modeling & Meta-Analysis, Patient-Centred Outcomes, Real-World Evidence, and Strategic Market Access.Pharmerit has offices in Berlin, Bethesda, Boston, Mumbai, Oxford, New York, Rotterdam, York, and Shanghai.
For further information on Pharmerit International, please visit www.pharmerit.com.
About Peloton Advantage, LLC:
Peloton Advantage, LLC is a privately-owned medical communications company specializing in strategic publication planning and associated content development for medical education programs. Peloton’s teams support US and global accounts for large and small pharmaceutical, biotechnology, and medical device companies, contributing to the success of more than 90 products spanning all major therapeutic areas.
For further information on Peloton Advantage, please visit www.pelotonadvantage.com.
This content was provided by OPEN Health
Company Details
Latest Content from OPEN Health
Spotlight interview: 15 minutes on digital in medical communications
Gemma Allen, Head of Digital Communications, OPEN Health takes 15 minutes to answer some key questions on digital in medical communications
Generating data on long-term outcomes with gene and other advanced therapies
Gene therapy and advanced cell-based therapies offer patients hope and the potential to make them ‘chronically well’.
Are you using Patient-Reported Outcomes (PROs) in your oncology trials? If not, why not?
A recent blog, published by Sarah Tressel Gary and Rinah Yamamoto called “Patient-Reported Outcome Data in Oncology Trials - Part 2: Clinical Benefit and Patient Preference”, has sparked our interest....
Spotlight interview: 15 minutes on insights and market research in pharma
Neil Rees, Head of Research, OPEN Health Patient & Brand Communication takes 15 minutes to answer some key questions on insights and market research in pharma
OPEN Health reflections on the World Orphan Drug Congress in Barcelona
Having just returned from a very busy but hugely enjoyable few days at congress, I wanted to share our views on the event and key themes that our healthcare communications...
Patient journey mapping: exploring the clinical and the emotional journey
By Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew While we can all agree that the value of developing a patient journey map cannot be underestimated when exploring the...
OPEN Health announces the integration of Pharmerit International into the group
OPEN Health has today announced the integration of Pharmerit International, a global leader in health economics and outcomes research (HEOR), into its group of companies.
OPEN Health mobilised to support outcomes with gene and other advanced therapies
Harnessing the power of collaborations to bring real insights and improve outcomes
Spotlight interview: 15 minutes on PR in pharma
Vicky Bramham, Managing Director, OPEN Health takes 15 minutes to answer some key questions on PR discipline.
OPEN Health PBC recognised as No. 1 independent creative agency
We’re No.1! PMLive have named OPEN Health Patient & Brand Communications as the no.1 independent creative healthcare agency. The aim of the PMLive Top 10 lists is to highlight those...